Ovics, P.; Regev, D.; Baskin, P.; Davidor, M.; Shemer, Y.; Neeman, S.; Ben-Haim, Y.; Binah, O.
Drug Development and the Use of Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Disease Modeling and Drug Toxicity Screening. Int. J. Mol. Sci. 2020, 21, 7320.
https://doi.org/10.3390/ijms21197320
AMA Style
Ovics P, Regev D, Baskin P, Davidor M, Shemer Y, Neeman S, Ben-Haim Y, Binah O.
Drug Development and the Use of Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Disease Modeling and Drug Toxicity Screening. International Journal of Molecular Sciences. 2020; 21(19):7320.
https://doi.org/10.3390/ijms21197320
Chicago/Turabian Style
Ovics, Paz, Danielle Regev, Polina Baskin, Mor Davidor, Yuval Shemer, Shunit Neeman, Yael Ben-Haim, and Ofer Binah.
2020. "Drug Development and the Use of Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Disease Modeling and Drug Toxicity Screening" International Journal of Molecular Sciences 21, no. 19: 7320.
https://doi.org/10.3390/ijms21197320
APA Style
Ovics, P., Regev, D., Baskin, P., Davidor, M., Shemer, Y., Neeman, S., Ben-Haim, Y., & Binah, O.
(2020). Drug Development and the Use of Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Disease Modeling and Drug Toxicity Screening. International Journal of Molecular Sciences, 21(19), 7320.
https://doi.org/10.3390/ijms21197320